Clinical Trial
Right Dorsolateral Prefrontal Cortex Closed-loop Neurofeedback for Anxiety in High-ischaemic-risk Chronic Coronary Syndrome (HEART-SET-3)
ClinicalTrials.gov4/19/2026ยท04/19/26๐ Asia
Summary
HEART-SET-3 is a randomized, sham-controlled, double-blinded trial of closed-loop neurofeedback using functional near-infrared spectroscopy (fNIRS), targeting the right dorsolateral prefrontal cortex. It aims to enroll 214 patients with chronic coronary syndrome at high ischemic risk who also have an anxiety disorder, to assess clinical efficacy, mechanisms and safety. Sponsor is Shenyang Medical College, and the registry lists it as not yet recruiting.
Why it matters
It applies a non-invasive brain-computer interface to a mental-health problem in cardiac patients, with a sham control. The sample is moderate in size and the trial has not yet started recruiting.
#Neural Interfaces#Neural Recording#fNIRS#Non-invasive#Anxiety#Asia
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items โ updated daily.
Start free trialAlready a member? Sign in